Dennis Schade

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

ACS pharmacology & translational science

Journal of medicinal chemistry

Archiv der Pharmazie

Molecules (Basel, Switzerland)

Christian-Albrechts-Universität zu Kiel

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Christian-Albrechts-Universität zu Kiel Aug 01 2018

Germany

Professor :: Pharmaceutical and Medicinal Chemistry

Publications

Daniel Längle, Stephanie Wojtowicz-Piotrowski, Till Priegann, Niklas Keller, Fabian Wesseler, Elena S Reckzeh, Karsten Steffens, Christoph Grathwol, Jana Lemke, Maren Flasshoff, Christian Näther, Anna C Jonson, Andreas Link, Oliver Koch, Gianni M Di Guglielmo, Dennis Schade
Expanding the Chemical Space of Transforming Growth Factor-β (TGFβ) Receptor Type II Degraders with 3,4-Disubstituted Indole Derivatives. ACS pharmacology & translational science 7 (4) (2024)
Felix Potlitz, Gottfried J Palm, Anja Bodtke, Michael Lammers, Dennis Schade, Andreas Link
A Novel C 3/ C 4-Fused Indole Scaffold through Acid-Catalyzed Cascade Reaction. Molecules (Basel, Switzerland) 29 (13) (2024)
Felix Potlitz, Gottfried J Palm, Anja Bodtke, Michael Lammers, Dennis Schade, Andreas Link
A Novel C 3/ C 4-Fused Indole Scaffold through Acid-Catalyzed Cascade Reaction. Molecules (Basel, Switzerland) 29 (13) (2024)
Daniel Längle, Stephanie Wojtowicz-Piotrowski, Till Priegann, Niklas Keller, Fabian Wesseler, Elena S Reckzeh, Karsten Steffens, Christoph Grathwol, Jana Lemke, Maren Flasshoff, Christian Näther, Anna C Jonson, Andreas Link, Oliver Koch, Gianni M Di Guglielmo, Dennis Schade
Expanding the Chemical Space of Transforming Growth Factor-β (TGFβ) Receptor Type II Degraders with 3,4-Disubstituted Indole Derivatives. ACS pharmacology & translational science 7 (4) (2024)
Daniel Längle, Stephanie Wojtowicz-Piotrowski, Till Priegann, Niklas Keller, Fabian Wesseler, Elena S Reckzeh, Karsten Steffens, Christoph Grathwol, Jana Lemke, Maren Flasshoff, Christian Näther, Anna C Jonson, Andreas Link, Oliver Koch, Gianni M Di Guglielmo, Dennis Schade
Expanding the Chemical Space of Transforming Growth Factor-β (TGFβ) Receptor Type II Degraders with 3,4-Disubstituted Indole Derivatives. ACS pharmacology & translational science 7 (4) (2024)
Sven Jirschitzka, Daniel Längle, Hendrik Lück, Dennis Schade, Thomas Kunze
Combined physicochemical and functional assessment of pertuzumab integrity supports extended in-use stability. Archiv der Pharmazie (2023)
Daniel Riege, Sven Herschel, Teresa Fenkl, Dennis Schade
Small-Molecule Probes as Pharmacological Tools for the Bone Morphogenetic Protein Signaling Pathway. ACS pharmacology & translational science 6 (11) (2023)
Daniel Riege, Sven Herschel, Linda Heintze, Teresa Fenkl, Fabian Wesseler, Sonja Sievers, Christian Peifer, Dennis Schade
Identification of Maleimide-Fused Carbazoles as Novel Noncanonical Bone Morphogenetic Protein Synergizers. ACS pharmacology & translational science 6 (8) (2023)
Sven Jirschitzka, Daniel Längle, Hendrik Lück, Dennis Schade, Thomas Kunze
Combined physicochemical and functional assessment of pertuzumab integrity supports extended in-use stability. Archiv der Pharmazie (2023)
Jana Flegel, Saad Shaaban, Zhi Jun Jia, Britta Schulte, Yilong Lian, Adrian Krzyzanowski, Malte Metz, Tabea Schneidewind, Fabian Wesseler, Anke Flegel, Alisa Reich, Alexandra Brause, Gang Xue, Minghao Zhang, Lara Dötsch, Isabelle D Stender, Jan-Erik Hoffmann, Rebecca Scheel, Petra Janning, Fraydoon Rastinejad, Dennis Schade, Carsten Strohmann, Andrey P Antonchick, Sonja Sievers, Pedro Moura-Alves, Slava Ziegler, Herbert Waldmann
The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation. Journal of medicinal chemistry (2022)
Fabian Wesseler, Daniel Riege, Mahesh Puthanveedu, Jonas Halver, Eva Müller, Jessica Bertrand, Andrey P Antonchick, Sonja Sievers, Herbert Waldmann, Dennis Schade
Probing Embryonic Development Enables the Discovery of Unique Small-Molecule Bone Morphogenetic Protein Potentiators. Journal of medicinal chemistry 65 (5) (2022)
Fabian Wesseler, Stefan Lohmann, Daniel Riege, Jonas Halver, Aileen Roth, Christian Pichlo, Sabrina Weber, Masanari Takamiya, Eva Müller, Jana Ketzel, Jana Flegel, Adrian Gihring, Sepand Rastegar, Jessica Bertrand, Ulrich Baumann, Uwe Knippschild, Christian Peifer, Sonja Sievers, Herbert Waldmann, Dennis Schade
Phenotypic Discovery of Triazolo[1,5- c ]quinazolines as a First-In-Class Bone Morphogenetic Protein Amplifier Chemotype. Journal of medicinal chemistry 65 (22) (2022)
Carmen Carrillo García, Cora Becker, Michael Forster, Stefan Lohmann, Patricia Freitag, Stefan A Laufer, Sonja Sievers, Bernd K Fleischmann, Michael Hesse, Dennis Schade
High-Throughput Screening Platform in Postnatal Heart Cells and Chemical Probe Toolbox to Assess Cardiomyocyte Proliferation. Journal of medicinal chemistry (2021)
Cintia Delai da Silva Horinouchi, Corien Oostendorp, Dennis Schade, Toin H van Kuppevelt, Willeke F Daamen
Growth factor mimetics for skin regeneration: In vitro profiling of primary human fibroblasts and keratinocytes. Archiv der Pharmazie 354 (8) (2021)
Ina Lunk, Felix-Alexander Litty, Sven Hennig, Ingrid R Vetter, Jürke Kotthaus, Karin S Altmann, Gudrun Ott, Antje Havemeyer, Carmen Carrillo García, Bernd Clement, Dennis Schade
Discovery of N-(4-Aminobutyl)-N'-(2-methoxyethyl)guanidine as the First Selective, Nonamino Acid, Catalytic Site Inhibitor of Human Dimethylarginine Dimethylaminohydrolase-1 (hDDAH-1). Journal of medicinal chemistry 63 (1) (2019)
Daniel Längle, Tessa R Werner, Fabian Wesseler, Elena Reckzeh, Niklas Schaumann, Lauren Drowley, Magnus Polla, Alleyn T Plowright, Marc N Hirt, Thomas Eschenhagen, Dennis Schade
Toward Second-Generation Cardiomyogenic and Anti-cardiofibrotic 1,4-Dihydropyridine-Class TGFβ Inhibitors. ChemMedChem 14 (8) (2019)

Dennis Schade.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dennis Schade